Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 242

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Development of CBT for chemotherapy‐related cognitive change: results of a waitlist control trial

Open access
Ferguson, Robert J., McDonald, Brenna C., Rocque, Michael A., Furstenberg, Charlotte T., Horrigan, Susan, Ahles, Tim A., Saykin, Andrew J.·2012·Psycho-Oncology

Abstract

Objective: To evaluate the efficacy of a brief cognitive‐behavioral therapy (CBT) that is being developed for management of cognitive dysfunction following chemotherapy among breast cancer survivors. Memory and Attention Adaptation Training (MAAT) is a brief CBT designed to improve the quality of life and function among cancer survivors with post‐chemotherapy cognitive complaints. Methods: An initial, two‐group (MAAT versus waitlist, no treatment control), randomized clinical trial (RCT) was conducted. Forty stage I and II female breast cancer survivors (mean age = 50; SD = 6.4) were randomized to conditions and assessed at baseline, post‐treatment (8 weeks) and 2‐month follow‐up assessment points on measures of: (1) self‐reported daily cognitive failures; (2) quality of life; and (3) neuropsychological performance. Participants were also assessed for satisfaction with MAAT. Results: With education and IQ as covariates, MAAT participants made significant improvements relative to controls on the spiritual well‐being subscale of the quality of life measure and on verbal memory, but statistical significance was not achieved on self‐report of daily cognitive complaints. However, moderate‐to‐large effect sizes were observed on these outcomes. Participants gave MAAT high satisfaction ratings. Conclusions: Although this initial RCT is a small study, MAAT participants appear to improve on one measure of quality of life and verbal memory performance relative to no treatment controls and rate MAAT with high satisfaction. These data are encouraging and support the continued development and evaluation of MAAT efficacy.Copyright © 2010 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pon.1878

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 54

  1. 10.1093/annonc/mdm500 · DOI · Paper page
  2. 10.1007/s11910-003-0081-2 · DOI
  3. 10.1200/JCO.2004.08.094 · DOI · Paper page
  4. 10.1200/JCO.2006.08.1604 · DOI · Paper page
  5. 10.1200/JCO.2000.18.14.2695 · DOI · Paper page
  6. 10.1080/14733400410001727583 · doi:10.1080/14733400410001727583
  7. Schagen S, 2006, Change in Cognitive Function After Chemotherapy: A Prospective Longitudinal Study in Breast Cancer Patients, © The Author 2006, 1742
  8. 10.1081/CNV-100107743 · DOI · Paper page
  9. 10.1200/JCO.2004.08.094 · DOI · Paper page
  10. 10.1038/nrc2073 · DOI · Paper page
  11. 10.1200/JCO.2007.10.8639 · DOI · Paper page
  12. 10.1007/s10549-006-9380-z · DOI · Paper page
  13. 10.1016/j.bbr.2007.04.003 · DOI
  14. 10.1200/JCO.2005.03.343 · DOI
  15. Vardy J, 2009, Cognitive function in survivors of cancer, Am Soc Clin Oncol Educational Book, 2009, 570
  16. 10.1002/pon.1133 · DOI · Paper page
  17. Reuben S, President's Cancer Panel 2003/2004
  18. 10.1007/s10552-005-0452-x · DOI
  19. Lower E, 2005, A phase III, randomized placebo‐controlled trial of the saftey adn efficcy of d‐mph as new treatment of fatigue and ‘emobrain’ in adult cancer patients, J Clin Oncol, 23, 729s
  20. Kohli S, 2007, The cognitive effects of modafinil in breast cancer survivors: a randomized clinical trail, J Clin Oncol, 25, 9004, 10.1200/jco.2007.25.18_suppl.9004 · DOI
  21. 10.1023/A:1026464827874 · DOI
  22. 10.1146/annurev.clinpsy.4.022007.141212 · DOI · Paper page
  23. 10.1037/a0013659 · DOI · Paper page
  24. 10.1007/s11065-009-9119-9 · DOI · Paper page
  25. Wagner LI, 2003, Chemotherapy‐related cognitive deficits: a qualitative examination of patients and providers, Ann Behav Med, 25, S056
  26. Vardy J, 2008, Relation between perceived cognitive function and neuropsychological performance in survivors of breast and colorectal, Cancer, 26, 9520
  27. 10.1001/jama.1994.03520220043029 · DOI · Paper page
  28. 10.1002/cncr.21482 · DOI
  29. Fan H, 2006, Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?, J Clin Oncol, 24, 5171
  30. 10.1002/cncr.24192 · DOI
  31. MeichenbaumD AsarnowJ.Cognitive‐behavioral modification and metacognitive development: implications for the classroom. Cognitive‐behavioral interventions: Theory research and procedures1979;1–35. · DOI · Paper page
  32. 10.1080/01688639408402620 · DOI · Paper page
  33. 10.1007/BF01806154 · DOI · Paper page
  34. 10.1177/014662167700100306 · DOI · Paper page
  35. 10.1016/S0022-3999(99)00004-5 · DOI · Paper page
  36. Spielberger C, 1977, Stai Manual
  37. 10.1200/JCO.2002.20.2.485 · DOI · Paper page
  38. Delis D, 2000, CVLT‐II, California Verbal Learning Test, Adult Version, Manual
  39. Delis D, 2001, D‐kefs Executive Function System Examiner's Manual
  40. Wechsler D., 1997, Wechsler Adult Intelligence Scale‐III (WAIS‐III)
  41. De Vaus D., 2002, Analyzing Social Science Data: 50 Key Problems in Data Analysis
  42. 10.1037/0022-006X.52.5.885 · doi:10.1037/0022-006x.52.5.885 · Paper page
  43. 10.1037/0022-006X.76.3.367 · DOI · Paper page
  44. 10.1007/s11910-003-0081-2 · DOI
  45. 10.1007/s11065-008-9058-x · DOI
  46. WagnerL LaiJ CellaD SweetJ ForrestalS.Chemotherapy‐related cognitive deficits: development of the fact‐cog instrument. Poster Presented at the 25th Annual Scientific Session of the Society of Behavioral Medicine Baltimore Maryland. Abstract: Annals of Behavioral Medicine2004;27.
  47. 10.1007/s10549-007-9686-5 · DOI · Paper page
  48. 10.1037/0022-006X.76.3.367 · DOI · Paper page
  49. 10.1037/10693-000 · DOI · Paper page
  50. Feuerstein M., 2006, Handbook of Cancer Survivorship
  51. Snijders T, 1999, Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling
  52. 10.1007/s00520-006-0037-6 · DOI
  53. WagnerL.Fact‐cog version 3 psychometric properties. ICCTF Workshop: Measuring Perceived Cognitive Function October 2008 Venice.
  54. 10.1200/JCO.2009.27.0827 · DOI · Paper page

Cited by

See all 242

Metadata

Authors
Ferguson, R. J., McDonald, B. C., Rocque, M. A., Furstenberg, C. T., Horrigan, S., Ahles, T. A., & Saykin, A. J.
Venue
Psycho-Oncology
Publisher
Wiley
Published
2010-12-02
Volume
21
Issue
2
Pages
176-186
ISSN
  • 1057-9249 (ISSN-L)
  • 1099-1611
OpenAlex
W2114455369
Cited by
242
References
4
FWCI
9.10
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.